Literature DB >> 16119438

Outbreak of typhoid fever in vaccinated members of the French Armed Forces in the Ivory Coast.

Rémy Michel1, Eric Garnotel, André Spiegel, Marc Morillon, Pierre Saliou, Jean-Paul Boutin.   

Abstract

In 2001, an outbreak of typhoid fever occurred among the members of the French Armed Forces. All had received a typhoid vaccination as per the immunization schedule practiced in the Armed Forces (every 5 years). A retrospective cohort study was conducted in 94 personnel. The objectives were to confirm the diagnosis, determine the source of contamination and identify the factors associated with defective vaccinal efficacy. Twenty-four cases were clinically identified. A cucumber salad was identified as the contaminating dish (Risk Ratio = 3.6; 95%CI 1.5-8.9). Only one factor was related to defective vaccinal efficacy; the risk of typhoid fever was two-fold higher in people vaccinated more than 3 years previously (Risk Ratio = 2.2; 95%CI, 1.1-4.2). Compliance with food hygiene rules could have prevented 24 cases of typhoid fever. Nevertheless, repeat vaccination against typhoid fever is now conducted every 3 years in the French Forces, in compliance with the manufacturers' recommendations.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16119438     DOI: 10.1007/s10654-005-7454-6

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  33 in total

Review 1.  A recently developed typhoid Vi polysaccharide vaccine: rationale and clinical profile.

Authors:  J N Zuckerman
Journal:  BioDrugs       Date:  2001       Impact factor: 5.807

2.  Safety and immunogenicity of two Salmonella typhi Vi capsular polysaccharide vaccines.

Authors:  C O Tacket; C Ferreccio; J B Robbins; C M Tsai; D Schulz; M Cadoz; A Goudeau; M M Levine
Journal:  J Infect Dis       Date:  1986-08       Impact factor: 5.226

3.  Immunogenicity, efficacy and serological correlate of protection of Salmonella typhi Vi capsular polysaccharide vaccine three years after immunization.

Authors:  K P Klugman; H J Koornhof; J B Robbins; N N Le Cam
Journal:  Vaccine       Date:  1996-04       Impact factor: 3.641

4.  Typhoid fever vaccines: a meta-analysis of studies on efficacy and toxicity.

Authors:  E A Engels; M E Falagas; J Lau; M L Bennish
Journal:  BMJ       Date:  1998-01-10

5.  Typhoid fever in group travelers: opportunity for studying vaccine efficacy.

Authors:  F G Cobelens; S Kooij; A Warris-Versteegen; L G Visser
Journal:  J Travel Med       Date:  2000-01       Impact factor: 8.490

6.  Protective activity of Vi capsular polysaccharide vaccine against typhoid fever.

Authors:  K P Klugman; I T Gilbertson; H J Koornhof; J B Robbins; R Schneerson; D Schulz; M Cadoz; J Armand
Journal:  Lancet       Date:  1987-11-21       Impact factor: 79.321

7.  Typhoid fever due to a Salmonella typhi strain of reduced susceptibility to fluoroquinolones.

Authors:  Odile Launay; Jean-Claude Nguyen Van; Annie Buu-Hoï; J. F. Acar
Journal:  Clin Microbiol Infect       Date:  1997       Impact factor: 8.067

8.  Quinolone-resistant Salmonella typhi in Viet Nam: molecular basis of resistance and clinical response to treatment.

Authors:  J Wain; N T Hoa; N T Chinh; H Vinh; M J Everett; T S Diep; N P Day; T Solomon; N J White; L J Piddock; C M Parry
Journal:  Clin Infect Dis       Date:  1997-12       Impact factor: 9.079

9.  Investigation of an outbreak of Salmonella typhi in a public school in Madrid.

Authors:  M A Usera; A Aladueña; A Echeita; E Amor; J L Gomez-Garcés; C Ibañez; I Mendez; J C Sanz; M Lopez-Brea
Journal:  Eur J Epidemiol       Date:  1993-05       Impact factor: 8.082

10.  Value of a single Widal test in the diagnosis of typhoid fever.

Authors:  R Rasaily; P Dutta; M R Saha; U Mitra; S K Bhattacharya; B Manna; A Mukherjee; S Chakravorty; S C Pal
Journal:  Indian J Med Res       Date:  1993-05       Impact factor: 2.375

View more
  11 in total

1.  Re: outbreak of typhoid fever in vaccinated members of the French Armed Forces in the Ivory Coast.

Authors:  Subhash C Arya; Nirmala Agarwal
Journal:  Eur J Epidemiol       Date:  2006-05-23       Impact factor: 8.082

Review 2.  Vaccination for typhoid fever in sub-Saharan Africa.

Authors:  Rachel B Slayton; Kashmira A Date; Eric D Mintz
Journal:  Hum Vaccin Immunother       Date:  2013-04-01       Impact factor: 3.452

3.  Gastrointestinal illnesses among French forces deployed to Djibouti: French military health surveillance, 2005-2009.

Authors:  Lénaïck Ollivier; Christophe Decam; Vincent Pommier de Santi; Houssein Y Darar; Aïssata Dia; Remington L Nevin; Olivier Romand; Jacques Bougère; Xavier Deparis; Jean-Paul Boutin
Journal:  Am J Trop Med Hyg       Date:  2010-10       Impact factor: 2.345

4.  Oral priming with Salmonella Typhi vaccine strain CVD 909 followed by parenteral boost with the S. Typhi Vi capsular polysaccharide vaccine induces CD27+IgD-S. Typhi-specific IgA and IgG B memory cells in humans.

Authors:  Rezwanul Wahid; Marcela F Pasetti; Milton Maciel; Jakub K Simon; Carol O Tacket; Myron M Levine; Marcelo B Sztein
Journal:  Clin Immunol       Date:  2010-12-10       Impact factor: 3.969

Review 5.  Incubation period of typhoidal salmonellosis: a systematic review and meta-analysis of outbreaks and experimental studies occurring over the last century.

Authors:  Adedoyin Awofisayo-Okuyelu; Noel McCarthy; Ifunanya Mgbakor; Ian Hall
Journal:  BMC Infect Dis       Date:  2018-09-27       Impact factor: 3.090

6.  Assessing the Impact of a Vi-polysaccharide Conjugate Vaccine in Preventing Typhoid Infections Among Nepalese Children: A Protocol for a Phase III, Randomized Control Trial.

Authors:  Katherine Theiss-Nyland; Mila Shakya; Rachel Colin-Jones; Merryn Voysey; Nicola Smith; Abhilasha Karkey; Sabina Dongol; Dikshya Pant; Yama G Farooq; Kathleen M Neuzil; Shrijana Shrestha; Buddha Basnyat; Andrew J Pollard
Journal:  Clin Infect Dis       Date:  2019-03-07       Impact factor: 9.079

7.  Assessing the Impact of a Vi-polysaccharide Conjugate Vaccine in Preventing Typhoid Infection Among Bangladeshi Children: A Protocol for a Phase IIIb Trial.

Authors:  Katherine Theiss-Nyland; Firdausi Qadri; Rachel Colin-Jones; K Zaman; Farhana Khanam; Xinxue Liu; Merryn Voysey; Arifuzzaman Khan; Nazmul Hasan; Fahim Ashher; Yama G Farooq; Andrew J Pollard; John D Clemens
Journal:  Clin Infect Dis       Date:  2019-03-07       Impact factor: 9.079

8.  Within-host mathematical modelling of the incubation period of Salmonella Typhi.

Authors:  Adedoyin Awofisayo-Okuyelu; Adrian Pratt; Noel McCarthy; Ian Hall
Journal:  R Soc Open Sci       Date:  2019-09-11       Impact factor: 2.963

9.  Toward Control? The Prospects and Challenges of Typhoid Conjugate Vaccine Introduction.

Authors:  Megan E Carey; Zoey I Diaz; Martin Broadstock; Roderick Bailey; Adwoa D Bentsi-Enchill; Heidi J Larson
Journal:  Clin Infect Dis       Date:  2019-10-15       Impact factor: 20.999

10.  Assessment of safety risks associated with pork meat sold on the market in Abidjan city (Côte d'Ivoire) using surveys and microbial testing.

Authors:  Kouame Kohi Alfred; Bouatenin Koffi Maïzan Jean-Paul; Coulibaly Wahauwouélé Hermann; Boraud Alloue Mirelle; Dje Koffi Marcellin
Journal:  Heliyon       Date:  2019-07-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.